|  |  | Incidence, % | Magnitude, % | |||
---|---|---|---|---|---|---|---|
Targeted Receptor | Drug | n | Inhibition | Facilitation | Neither | Inhibition | Facilitation |
D1, D2 | DA | 29 | 83 | 10 | 7 | 49 | 117 |
 | SKF & Quin | 4 | 75 | 0 | 25 | 88 | n/a |
D1 | SKF | 12 | 50 | 33 | 17 | 84 | 136 |
 | DA & Sulp | 10 | 60 | 20 | 20 | 54 | 127 |
D2 | Quin | 14 | 71 | 21 | 7 | 66 | 109 |
 | DA & SCH | 10 | 70 | 10 | 20 | 59 | 110 |
Monoamine | NE | 2 | 100 | 0 | 0 | 48 | n/a |
 | 5-HT | 5 | 80 | 0 | 20 | 52 | n/a |